A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fasting Condition
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2012-02-09
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT01523080
- Locations
- 🇮🇳
Clinical Pharmacology Unit, Majeedia Hospital (2nd Floor), New Delhi, India
Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2012-02-09
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 35
- Registration Number
- NCT01523119
- Locations
- 🇮🇳
Clinical Pharmacology Unit, Majeedia Hospital (2nd Floor), New Delhi, India
Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2012-02-09
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT01523093
- Locations
- 🇮🇳
Clinical Pharmacology Unit, Majeedia Hospital (2nd Floor), New Delhi, India
A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fed Condition
- First Posted Date
- 2012-01-20
- Last Posted Date
- 2012-01-31
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT01513668
- Locations
- 🇮🇳
Clinical Pharmacology Unit, B-22, Sector 62, Noida, Uttar Pradesh, India
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 80
- Registration Number
- NCT01499758
- Locations
- 🇺🇸
Cetero Research 4801 Amber Valley Parkway, Fargo, North Dakota, United States
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 80
- Registration Number
- NCT01499771
- Locations
- 🇺🇸
Cetero Research 4801 Amber Valley Parkway, Fargo, North Dakota, United States
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions
- First Posted Date
- 2011-01-13
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT01276080
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions
- First Posted Date
- 2011-01-13
- Last Posted Date
- 2012-07-20
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT01276067
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh,, Pennsylvania, United States
Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2010-10-18
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT01222923
- Locations
- 🇺🇸
aaiPharma Inc., Chapel Hill, North Carolina, United States
A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting Condition
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2010-10-18
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT01222910
- Locations
- 🇮🇳
Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India